country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-163515

Copy Link Print Information

Anticancer agent 207

Anticancer agent 207 (compound 10b) is a potent anticancer agent. Anticancer agent 207 bounds to the NRAS rG4 with a K_D value of 2.31 µM. Anticancer agent 207 shows cytotoxicity and decreases the expression of NRAS protein. Anticancer agent 207 shows antitumor activity.

For research use only. We do not sell to patients.

Formula: C₂₉H₃₉FN₄O₂
Molecular Weight:494.64

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (271 KB)

Anticancer agent 207 Chemical Structure

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Purity & Documentation
References
Calculators
Help & FAQs
Bioz

Biological Activity

Description

IC₅₀ & Target^[1]

NRAS rG4

2.31 μM (Kd)

All Ras Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
A-375	IC₅₀	4.5 μM Compound: 10b	Cytotoxicity against human A-375 cells incubated for 48 hrs by MTT assay Cytotoxicity against human A-375 cells incubated for 48 hrs by MTT assay	[PMID: 38688064]
HepG2	IC₅₀	1.5 μM Compound: 10b	Cytotoxicity against human HepG2 cells incubated for 48 hrs by MTT assay Cytotoxicity against human HepG2 cells incubated for 48 hrs by MTT assay	[PMID: 38688064]
HL-60	IC₅₀	2.7 μM Compound: 10b	Cytotoxicity against human HL-60 cells incubated for 48 hrs by MTT assay Cytotoxicity against human HL-60 cells incubated for 48 hrs by MTT assay	[PMID: 38688064]
MCF7	IC₅₀	4.1 μM Compound: 10b	Cytotoxicity against human MCF7 cells incubated for 48 hrs by MTT assay Cytotoxicity against human MCF7 cells incubated for 48 hrs by MTT assay	[PMID: 38688064]
SK-MEL-2	IC₅₀	2 μM Compound: 10b	Cytotoxicity against human SK-MEL-2 cells incubated for 48 hrs by MTT assay Cytotoxicity against human SK-MEL-2 cells incubated for 48 hrs by MTT assay	[PMID: 38688064]

In Vitro

Anticancer agent 207 (48 h) shows cytotoxicity for NRAS-mutant melanoma SK-MEL-2 with an IC₅₀ value of 2.0 µM^[1].
Anticancer agent 207 (0, 0.5, 1.0 µM; 72 h) decreases the expression of NRAS protein^[1].
Anticancer agent 207 (0, 0.13, 0.25 µM; 10 days) inhibits the colony formation of SK-MEL-2 cells^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

SK-MEL-2 cells
Concentration:

0, 0.5, 1.0 µM
Incubation Time:

72 h
Result:

Decreased the expression of NRAS protein in a dose-dependent manner.

Cell Proliferation Assay^[1]

Cell Line:

MCF-7, HepG2, HL60, A375 cells
Concentration:

0-100 µM
Incubation Time:

48 h
Result:

Showed cytotoxicity with IC₅₀s of 4.1, 1.5, 2.7, 4.5 µM for MCF-7, HepG2, HL60, A375 cells, respectively.

In Vivo

Anticancer agent 207 (1 mg/kg; i.p.; every day for 21 days) inhibits tumor growth in volume and weight in mice^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Six-week-old male BALB/C nude mice (SK-MEL-2 xenograft mouse model)^[1]
Dosage:

1 mg/kg
Administration:

I.p.; every day for 21 days
Result:

Suppressed tumor growth in volume and weight in the xenograft mouse model time-dependently.

Chemical Information

Molecular Weight 494.64
Formula C₂₉H₃₉FN₄O₂
SMILES

CCCCN(CCCOC1=CC=C2N=C3C4=C(OC3=C(C2=C1)NCCCN)C=CC(F)=C4)CCCC
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (271 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Jia-Wei Sun, et al. Design, synthesis, and evaluation of novel quindoline derivatives with fork-shaped side chains as RNA G-quadruplex stabilizers for repressing oncogene NRAS translation. European Journal of Medicinal Chemistry. 2024, 271(5): 116406.

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

100 mg

Get Quote In-stock